Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
11m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
38m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
38m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
39m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Incyte Corporation logo

Incyte Corporation

About

Incyte Corporation (NASDAQ:INCY) — investor relations, events, news, and company updates on 6ix.

Latest News

Today
Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates
Apr 2 2026
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Mar 28 2026
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Mar 25 2026
Incyte Announces Executive Leadership Appointments
Mar 20 2026
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting

Financials

Revenue
$5.14 B
Market Cap
$19.09 B
P/E Ratio
14.97
EPS
6.41

Community Chat

Ask AI

6ix6ixAIEvents